Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.

This Breast Cancer Awareness Month (October), an oncologist explains the different types of breast cancer, how they are ...

Dr. Schwartz answers the question: 'Difference between in situ breast cancers?' — -- Question: What is the difference between ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS)?

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

Please provide your email address to receive an email when new articles are posted on . Researchers have developed an AI model capable of using an inexpensive, easy-to-obtain chromatin image to ...

Doctors may soon be able to help women with early-stage breast cancer avoid unnecessary and aggressive treatments, thanks to ...

Some women undergo unnecessary mastectomy and chemotherapy, but a "labyrinth in a chip" could reveal which cancers need ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer. According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium ...

Ductal carcinoma in situ (DCIS) is a type of preinvasive tumor that sometimes progresses to a highly deadly form of breast cancer. It accounts for about 25 percent of all breast cancer diagnoses.